Almirall (LBTSF) Stock Price, News & Analysis

Company Overview

Almirall is a research-driven pharmaceutical company headquartered in Barcelona, Spain. Founded in 1943, the firm has evolved into a specialist in dermatology, dedicating its efforts to understanding and treating a range of inflammatory and chronic skin conditions. Over the decades, Almirall has built a reputation for its targeted R&D approach and its commitment to improving patient outcomes in dermatological care.

The company’s core activities span the research, development, manufacturing and marketing of prescription therapies for skin diseases. Its marketed portfolio includes products such as Actikerall, a topical treatment for actinic keratosis; Solaraze, a diclofenac-based gel for actinic keratosis and superficial basal cell carcinoma; and Skilarence (apremilast), an oral therapy for plaque psoriasis. Almirall’s pipeline features investigational small molecules and biologics aimed at conditions like eczema, hidradenitis suppurativa and other inflammatory dermatoses.

Almirall operates across Europe, North America and Latin America, leveraging a network of subsidiaries, local partnerships and strategic alliances to distribute its products. The company maintains research centres in Barcelona and other European locations, collaborating with academic institutions and biotech firms to accelerate innovation. Looking ahead, Almirall continues to pursue growth in its core dermatology franchise while exploring adjacent opportunities through licensing deals and co-development agreements.

Key Stats

• Today's Range: $13.36 to $13.36
• 50-Day Range: $13.36 to $13.36
• 52-Week Range: $9.01 to $13.36
• Volume: N/A
• Average Volume: 200 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LBTSF Stock Analysis - Frequently Asked Questions

How have LBTSF shares performed this year?

Almirall's stock was trading at $9.1730 at the beginning of 2025. Since then, LBTSF shares have increased by 45.6% and is now trading at $13.36.

How do I buy shares of Almirall?

Shares of LBTSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 10/17/2025
• Next Earnings (Estimated): 11/10/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:LBTSF
• CIK: N/A
• Web: www.almirall.com
• Phone: 34 93 291 30 00
• Fax: N/A
• Employees: 1,996
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A